| 标题 |
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Escrivá-de-Romani S; Cejalvo JM; Alba E; Friedmann J; Rodríguez-Lescure Á; et al 出版日期:2025/06/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)